Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Advanced melanoma

BMS skin cancer drug hits US regulatory delay

November 3, 2010 Research and Development BMS, Bristol-Myers Squibb, FDA, MDX010-020 trial, ipilimumab, skin cancer

US regulators have announced they need more time to assess Bristol-Myers Squibb’s skin cancer treatment ipilimumab. The FDA will not …
News

Almirall and Forest’s phase III COPD drug misses goal

November 3, 2010 Research and Development Aclidinium bromide, Almirall, COPY, Forest, Forest Laboratories, chronic obstructive pulmonary disease

Almirall and Forest’s COPD drug aclidinium bromide has disappointed in a phase III trial by producing fewer benefits than found …
News
Lilly scientists

Lilly to open diabetes research centre in China

November 2, 2010 Research and Development China, Eli Lilly & Co, Lilly Research Laboratories in China, diabetes, lilly

The march of foreign pharma companies into China is to continue with Eli Lilly and Co’s opening of a diabetes …
News

Nycomed expands China presence with Techpool stake

November 2, 2010 Research and Development, Sales and Marketing China, Guangdong Techpool biopharma, Nycomed, emerging markets, emerging pharma markets

Swiss-based Nycomed has acquired a majority stake in Guangdong Techpool biopharma in China, extending its presence in the top tier …
News

Abbott hep C drug ABT-450/r impresses in mid-stage trial

November 2, 2010 Research and Development ABT-450/r, Abbott, Abbott Laboratories, American Liver Disease congress, Enanta Pharmaceuticals, Norvir, hepatitis C

Mid-stage trial results of Abbott Laboratories’ oral hepatitis C drug ABT-450/r have impressed at the American Liver Disease congress. The …
News

Lundbeck UK appoints senior management team

November 2, 2010 Research and Development, Sales and Marketing Amanda Badrick, Andy Davis, Andy Jones, Helen Carberry, Lundbeck, Steve Ferguson, appointment, recruitment, research and development, sales and marketing

Lundbeck UK has formed a new senior management team, appointing Steve Ferguson, Andy Davis, Andy Jones, Helen Carberry and Amanda …
News

Regulators must catch up with medical science, says FDA

November 2, 2010 Research and Development, Sales and Marketing Advancing Regulatory Science, Critical Path Initiative’, Dr Margaret Hamburg, FDA, regulatory affairs

The head of the FDA has declared a need for ‘regulatory science’ to catch up with the advances in medical …
News

‘Therapeutic clusters’ collaboration launched

November 2, 2010 Research and Development ABPI, BIA, Immunology Initiative, Medical Research Council, Office for Strategic Co-ordination of Health and Research, Therapeutic Capability Clusters’, UCB, therapeutic clusters

Two initiatives linking the pharma industry and government-funded research and academia are to go ahead, with the aim of reviving …
News

6 tips for regulatory compliance in logistics

November 2, 2010 Manufacturing and Production, Research and Development Biocair, GMP, International Council for Harmonisation, pharma logistics, regulatory compliance

Regulation! Regulation! Regulation! Never has our business been more highly regulated than it is today. Seemingly, rules change every day. …
Feature

Relief as life sciences spared in UK cutbacks

November 1, 2010 Research and Development ABPI, Comprehensive Spending Review, Diamond Synchrotron, UK Centre for Medical Research Innovation, UKCMRI, government, science funding

UK government funding for life sciences R&D has been spared from the deep cuts some had feared. Many in the …
News

Pfizer to seek US approval for crizotinib next year

November 1, 2010 Research and Development, Sales and Marketing FDA submission, NSCLC, Pfizer, crizotinib, lung cancer, non-small cell lung cancer

Pfizer will submit its lung cancer candidate crizotinib to the FDA for US approval in the first half of next …
News

GSK signs rare diseases deal with Amicus

November 1, 2010 Research and Development, Sales and Marketing Amicus Therapeutics, Fabrazyme, Fabry disease, GSK, GlaxoSmithKline, pharmacological chaperones

GlaxoSmithKline is partnering with US biopharmaceutical company Amicus Therapeutics to develop and commercialise its late-stage Fabry disease drug Amigal. GSK …
News

Intercell appoints Staph Leavenworth Bakali

October 27, 2010 Research and Development Intercell, Staph Leavenworth Bakali, appointment, research and development

Austrian biotech company Intercell has appointed Staph Leavenworth Bakali as chief business officer. He will have key responsibilities for the …
Appointment

Contract research news in brief

October 27, 2010 Research and Development Almac, Kinaxo, MediData Solutions, Quintiles, Ricerca Biosciences, Southern Research Institute, Venn Life Sciences, biofocus, contract research

Our latest crop of contract research news includes updates from Quintiles, Venn Life Sciences, Medidata Solutions, Southern Research Institute, Ricerca …
News

Health outcomes – does anything else matter?

October 27, 2010 Research and Development Les Rose, evidence-based medicine, healthcare outcomes, randomised controlled trials

So the mould of British politics has been broken, and we now have a government with probably a broader range …
Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026